Coronary heart disease and hormone replacement therapy after the menopause

Climacteric

Volumn 12, Issue SUPPL. 1, 2009, Pages 71-75

  Hodis, H N ^a   MacK, W J ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

CORONARY HEART DISEASE; ESTROGEN; HORMONE REPLACEMENT THERAPY; MENOPAUSE; MORTALITY; OBSERVATIONAL STUDIES; POSTMENOPAUSAL; RANDOMIZED CONTROLLED TRIALS

Indexed keywords

CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; PLACEBO; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; HORMONE SUBSTITUTION; HUMAN; ISCHEMIC HEART DISEASE; MEDICAL LITERATURE; MENOPAUSAL SYNDROME; MENOPAUSE; OBSERVATIONAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK BENEFIT ANALYSIS; AGE; CASE CONTROL STUDY; COHORT ANALYSIS; CORONARY ARTERY DISEASE; ESTROGEN THERAPY; FEMALE; MORTALITY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT;

AGE FACTORS; CASE-CONTROL STUDIES; COHORT STUDIES; CORONARY DISEASE; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT;

EID: 73949124497     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130903095178     Document Type: Article

References (15)

1. Grodstein F, Stampfer M. The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Prog Cardiol Dis 1995;38:199-210
2. Hodis HN, Mack WJ. Postmenopausal hormone therapy and cardiovascular disease in perspective. Clin Obstet Gynecol 2008;51:564-80
3. Salpeter SR, Walsh JM, Greyber E, Salpeter EE. Coronary heart disease events associated with hormone therapy in younger and older women: a meta-analysis. J Gen Intern Med 2006;21:363-6
4. Rossouw JE, Prentice RL, Manson JA, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007;297:1465-77 (Pubitemid 46556472)
5. Hsia J, Langer RD, Manson JE, et al. Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative. Arch Intern Med 2006;166:357-65 (Pubitemid 43244325)
6. Collins P, Mosca L, Geiger MJ, et al. Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for the Heart Trial: results of subgroup analyses by age and other factors. Circulation 2009;119:922-30
7. Salpeter SR, Walsh JME, Greyber E, Ormiston TM, Salpeter EE. Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis. J Gen Intern Med 2004;19:791-804 (Pubitemid 38951954)
8. Chilvers CED, Knibb RC, Armstrong SJ, et al. Postmenopausal hormone replacement therapy and risk of acute myocardial infarction: a case control study of women in the East Midlands, UK. Eur Heart J 2003;24:2197-205 (Pubitemid 37522672)
9. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998;280:605-13 (Pubitemid 28502636)
10. Manson JE, Hsia J, Johnson KC, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003;349:523-34 (Pubitemid 36951364)
11. Prentice RL, Langer R, Stefanick ML, et al. Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone therapy and cardiovascular disease. Am J Epidemiol 2006;163:589-99
12. Prentice RL, Langer R, Stefanick ML, et al. Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial. Am J Epidemiol 2005;162:404-14 (Pubitemid 41191425)
13. Hodis HN, Mack WJ. Postmenopausal hormone therapy in clinical perspective. Menopause 2007;14:944-57 (Pubitemid 47517597)
14. Walsh JE, Pignone M. Drug treatment of hyperlipidemia in women. JAMA 2004;291:2243-52 (Pubitemid 38608174)
15. Ridker PM, Cook NR, Lee IM, et al. A randomized controlled trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005;352:1293-304